Identificador persistente para citar o vincular este elemento: http://hdl.handle.net/10553/48626
Campo DC Valoridioma
dc.contributor.authorSøyland, E.en_US
dc.contributor.authorHeier, Ingvilden_US
dc.contributor.authorRodríguez-Gallego, C.en_US
dc.contributor.authorMollnes, T. E.en_US
dc.contributor.authorJohansen, F. E.en_US
dc.contributor.authorHolven, K. B.en_US
dc.contributor.authorHalvorsen, B.en_US
dc.contributor.authorAukrust, P.en_US
dc.contributor.authorJahnsen, F. L.en_US
dc.contributor.authorDe La Rosa Carrillo, D.en_US
dc.contributor.authorKrogstad, A. L.en_US
dc.contributor.authorNenseter, M. S.en_US
dc.date.accessioned2018-11-23T23:30:59Z-
dc.date.available2018-11-23T23:30:59Z-
dc.date.issued2011en_US
dc.identifier.issn0007-0963en_US
dc.identifier.urihttp://hdl.handle.net/10553/48626-
dc.description.abstractBackground Ultraviolet (UV) radiation has immunosuppressive effects and heliotherapy is a well-described treatment modality for psoriasis. Objectives To characterize early sun-induced immunological changes both local and systemic in patients with psoriasis. Methods Twenty patients with moderate to severe psoriasis were subjected to controlled sun exposure on Gran Canaria, Canary Islands, Spain. Psoriasis Area and Severity Index (PASI) scores were evaluated. Skin biopsies were obtained from lesional and nonlesional skin in 10 patients at baseline and on day 16 and from five additional patients on day 2. Specimens were examined with immunohistochemistry and polymerase chain reaction. Blood samples were obtained from all patients at the same time points and were examined for T-cell subsets and cytokine production. Results Significant clinical improvement was achieved during the study period. CD4+ and CD8+ T cells in lesional skin were significantly reduced in both the epidermis and dermis. In contrast, dermal FOXP3+ T cells were relatively increased. In the peripheral blood skin homing cutaneous lymphocyte-associated antigen (CLA)+ T cells were significantly decreased after only 1 day in the sun and in vitro stimulated peripheral blood mononuclear cells demonstrated reduced capacity to secrete cytokines after 16 days. Conclusions Our data show that clinical improvement of psoriasis following sun exposure is preceded by a rapid reduction in local and systemic inflammatory markers, strongly suggesting that immune modulation mediated the observed clinical effect. We cannot completely rule out that other mechanisms, such as stress reduction, may contribute, but it is extensively documented that UV irradiation is a potent inducer of immunosuppression and we therefore conclude that the observed effect was primarily due to sun exposure.en_US
dc.languageengen_US
dc.relation.ispartofBritish journal of dermatology (1951. Print)en_US
dc.sourceBritish Journal of Dermatology[ISSN 0007-0963],v. 164, p. 344-355 (febrero 2011)en_US
dc.subject32 Ciencias médicasen_US
dc.subject320106 Dermatologíaen_US
dc.subject.otherAutoimmune skin diseasesen_US
dc.subject.otherTumour necrosis factoren_US
dc.subject.otherPsoriasisen_US
dc.titleSun exposure induces rapid immunological changes in skin and peripheral blood in patients with psoriasisen_US
dc.typeinfo:eu-repo/semantics/articleen_US
dc.typeArticleen_US
dc.identifier.doi10.1111/j.1365-2133.2010.10149.xen_US
dc.identifier.scopus79551486070-
dc.contributor.authorscopusid7003664609-
dc.contributor.authorscopusid24068456400-
dc.contributor.authorscopusid6602114379-
dc.contributor.authorscopusid35597368000-
dc.contributor.authorscopusid55666390300-
dc.contributor.authorscopusid6603578893-
dc.contributor.authorscopusid7003740090-
dc.contributor.authorscopusid56771586600-
dc.contributor.authorscopusid7003464918-
dc.contributor.authorscopusid6508009048-
dc.contributor.authorscopusid6603713056-
dc.contributor.authorscopusid40262107100-
dc.description.lastpage355en_US
dc.description.firstpage344en_US
dc.relation.volume164en_US
dc.investigacionCiencias de la Saluden_US
dc.type2Artículoen_US
dc.description.numberofpages12en_US
dc.utils.revisionen_US
dc.date.coverdateFebrero 2011en_US
dc.identifier.ulpgcen_US
dc.contributor.buulpgcBU-MEDen_US
dc.description.sjr1,902-
dc.description.jcr3,666-
dc.description.sjrqQ1-
dc.description.jcrqQ1-
dc.description.scieSCIE-
item.fulltextSin texto completo-
item.grantfulltextnone-
crisitem.author.deptGIR IUIBS: Farmacología Molecular y Traslacional-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Ciencias Médicas y Quirúrgicas-
crisitem.author.orcid0000-0002-4344-8644-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.fullNameRodríguez Gallego, José Carlos-
Colección:Artículos
Vista resumida

Citas SCOPUSTM   

53
actualizado el 14-abr-2024

Visitas

30
actualizado el 12-ago-2023

Google ScholarTM

Verifica

Altmetric


Comparte



Exporta metadatos



Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.